Defibrillator Implantation in Patients with Nonischemic Systolic Heart FailureLars Køber, Steen Pehrson, Hans Eiskjær et al.|New England Journal of Medicine|2016Cited by 1.7k
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled TrialAnders Jorsal, Lise Tarnow, Caroline Kistorp et al.|European Journal of Heart Failure|2016Cited by 561
Prevalence and Prognostic Significance of Hyponatraemia in Outpatients with Chronic Heart FailureLouise Balling, Finn Gustafsson, Morten Schou et al.|European Journal of Heart Failure|2011Cited by 75
Patient Adherence to Evidence-Based Pharmacotherapy in Systolic Heart Failure and the Transition of Follow-Up from Specialized Heart Failure Outpatient Clinics to Primary CareAnne Gjesing, Gunnar Gislason, Morten Schou et al.|European Journal of Heart Failure|2013Cited by 48
Risk Models for Prediction of Implantable Cardioverter-Defibrillator BenefitSøren Lund Kristensen, Jens Jakob Thune, Wayne C. Levy et al.|JACC Heart Failure|2019Cited by 43